1. Home
  2. OPLN vs CPRX Comparison

OPLN vs CPRX Comparison

Compare OPLN & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OPENLANE Inc.

OPLN

OPENLANE Inc.

N/A

Current Price

$29.66

Market Cap

3.2B

Sector

N/A

ML Signal

N/A

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

HOLD

Current Price

$24.95

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPLN
CPRX
Founded
2006
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.9B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
OPLN
CPRX
Price
$29.66
$24.95
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$32.00
$35.00
AVG Volume (30 Days)
807.6K
927.6K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.24
EPS
N/A
1.68
Revenue
N/A
$119,072,803.00
Revenue This Year
$8.66
$9.20
Revenue Next Year
$6.14
$10.51
P/E Ratio
N/A
$14.85
Revenue Growth
N/A
16.39
52 Week Low
$25.81
$19.05
52 Week High
$31.78
$26.56

Technical Indicators

Market Signals
Indicator
OPLN
CPRX
Relative Strength Index (RSI) 62.12 56.40
Support Level $29.48 $22.24
Resistance Level $31.55 N/A
Average True Range (ATR) 0.71 0.65
MACD 0.29 0.18
Stochastic Oscillator 77.75 70.34

Price Performance

Historical Comparison
OPLN
CPRX

About OPLN OPENLANE Inc.

Openlane Inc provides a digital marketplace for used vehicles, connecting sellers and buyers in North America and Europe for fast and transparent transactions. Its services include financing, repossessions, repairs, transportation, warranty, and inventory management. The company operates used-vehicle auctions and has two main segments: Marketplace and Finance, with majority revenue coming from the Marketplace segment, which to used vehicle remarketing, including marketplace services, remarketing, or make ready services and all are interrelated, synergistic elements along the auto remarketing chain. The Finance segment, through AFC engaged in business of providing short-term, inventory-secured financing to independent vehicle dealers.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Share on Social Networks: